Gsg Advisors LLC Cor Medix Inc. Transaction History
Gsg Advisors LLC
- $317 Billion
- Q4 2024
A detailed history of Gsg Advisors LLC transactions in Cor Medix Inc. stock. As of the latest transaction made, Gsg Advisors LLC holds 26,500 shares of CRMD stock, worth $274,275. This represents 0.07% of its overall portfolio holdings.
Number of Shares
26,500
Previous 37,500
29.33%
Holding current value
$274,275
Previous $304 Million
29.33%
% of portfolio
0.07%
Previous 0.1%
Shares
4 transactions
Others Institutions Holding CRMD
# of Institutions
130Shares Held
19.8MCall Options Held
414KPut Options Held
467K-
Black Rock Inc. New York, NY3.55MShares$36.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.38MShares$35 Million0.0% of portfolio
-
Paul Singer Elliott Investment Management L.P. | West Palm Beach, Fl2.87MShares$29.7 Million0.14% of portfolio
-
State Street Corp Boston, MA1.45MShares$15 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.39MShares$14.4 Million0.0% of portfolio
About CorMedix Inc.
- Ticker CRMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,208,200
- Market Cap $427M
- Description
- CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...